Back to
JPMorgan Chase & Co.
ANVS
8 quarters
Position history for
JPMorgan Chase & Co.'s holdings in Annovis Bio, Inc.
Yes. JPMorgan Chase holds 15,219 shares of ANVS (Annovis Bio), worth $28,307, as of its Q2 2026 13F filing. It increased the position by 319 shares (+2.1%) from Q1 2026. JPMorgan Chase has held ANVS in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$28,307
Current Shares
15,219
Total Value Change
-$2,321
Total Shares Change
+11,419
Quarter-by-Quarter History
Other major holders of ANVS: Voloridge Investment Management, LLC, Adage Capital Partners GP, L.L.C., Marshall Wace, LLP, Geode Capital Management, LLC